CCL5 and neoplasm: An additional comparison was conducted among the controls, stage 0 –II cases, and stage III–IV cases, and all 13 plasma cytokines, except IFN-γ and RANTES, showed an increasing trend according to tumour progression (S1 Table and S1 Fig).